Guidance for Industry: Suicidal Ideation and Behavior: Prospective Assessment of Occurrence in Clinical Trials
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 13, 2012
February 25, 2022
c258943d-f6d1-4ddb-b590-e1b38509aab4
Related Documents
Alcoholism: Developing Drugs for Treatment
Guidance DocumentFebruary 12, 2015Center for Drug Evaluation and Research
Assessment of Pressor Effects of Drugs Guidance for Industry: Draft Guidance for Industry
Guidance DocumentFebruary 3, 2022Center for Drug Evaluation and Research
Gastroparesis: Clinical Evaluation of Drugs for Treatment Guidance for Industry
Guidance DocumentAugust 13, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox